Q3 2016 Holdings
Filed 2016-11-14 | 22 holdings | $166.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris therapeutics(ACRS) | Common | 00461U105 | $107.3M | 4,191,397 | 64.5% |
| Ascendis Pharma(ASND) | ADR | 04351P101 | $35.5M | 1,766,832 | 21.3% |
| Codexis, Inc.(CDXS) | Common | 192005106 | $23.5M | 5,294,825 | 14.1% |
| Eiger BioPharmaceuticals(CLDNEUR) | Common | 28249U105 | $23.9K | 1,787,091 | 0.0% |
| Nabriva Therapeutics AG | ADR | 62957M104 | $22.2K | 3,151,700 | 0.0% |
| Advanced Accelerator Applications S.A. | Common | 00790T100 | $17.4K | 455,798 | 0.0% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common | 00847L100 | $14.1K | 2,019,955 | 0.0% |
| Regenxbio Inc.(RGNX) | Common | 75901B107 | $13.9K | 990,449 | 0.0% |
| Trevena, Inc. | Common | 89532E109 | $11.7K | 1,728,000 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | Common | 00900T107 | $11.4K | 763,009 | 0.0% |
| CoLucid Pharmaceuticals, Inc. | Common | 19716T101 | $8.6K | 225,000 | 0.0% |
| Foamix Pharmaceuticals Ltd. | Common | M46135105 | $7.9K | 855,000 | 0.0% |
| Capnia, Inc. | Common | 14066L105 | $6.7K | 7,456,984 | 0.0% |
| Akari Therapeutics Plc | ADR | 00972G108 | $4.5K | 527,842 | 0.0% |
| ProNAi Therapeutics, Inc. | Common | 74346L101 | $4.4K | 2,438,270 | 0.0% |
| Dynavax Technologies Corporation(DVAX) | Common | 268158201 | $3.8K | 359,828 | 0.0% |
| Carbylan Therapeutics | Common | 141384107 | $1.9K | 4,204,562 | 0.0% |
| ReVance Therapeutics, Inc.(RVNCEUR) | Common | 761330109 | $1.3K | 77,373 | 0.0% |
| Ocera Therapeutics, Inc. | Common | 67552A108 | $405 | 153,331 | 0.0% |
| Capnia, Inc. | Warrant | 14066L113 | $198 | 943,858 | 0.0% |
| Palatin Technologies, Inc. | Common | 696077403 | $148 | 234,909 | 0.0% |
| Zosano Pharma Corp | Common | 98979H103 | $78 | 98,515 | 0.0% |